The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001754.5(RUNX1):c.1266G>A (p.Glu422=)

CA512341158

1154966 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 8ee9ee01-a92a-42d8-8240-4946c5d7940e
Approved on: 2022-04-25
Published on: 2022-07-05

HGVS expressions

NM_001754.5:c.1266G>A
NM_001754.5(RUNX1):c.1266G>A (p.Glu422=)
NC_000021.9:g.34792312C>T
CM000683.2:g.34792312C>T
NC_000021.8:g.36164609C>T
CM000683.1:g.36164609C>T
NC_000021.7:g.35086479C>T
NG_011402.2:g.1197400G>A
ENST00000675419.1:c.1266G>A
ENST00000300305.7:c.1266G>A
ENST00000344691.8:c.1185G>A
ENST00000399240.5:c.993G>A
ENST00000437180.5:c.1266G>A
ENST00000482318.5:c.*856G>A
NM_001001890.2:c.1185G>A
NM_001754.4:c.1266G>A
NM_001001890.3:c.1185G>A
More

Likely Benign

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Conflicting Evidence"
Met criteria codes 3
PM2_Supporting BP4 BP7
Not Met criteria codes 23
PM6 PM1 PM5 PM3 PM4 BA1 BS2 BS4 BS3 BS1 BP2 BP3 BP1 BP5 PS2 PS4 PS3 PS1 PVS1 PP1 PP4 PP3 PP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.1266G>A (p.Glu422=) is a synonymous variant. REVEL score not calculable. SpliceAI predicts: Acceptor loss 0.00, Donor loss 0.00, Acceptor gain 0.00, Donor gain 0.00 (BP4). Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score -0.378488 < 2.0 or the variant is the reference nucleotide in one primate and/or three mammal species) (BP7). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7, PM2_supporting.
Met criteria codes
PM2_Supporting
This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2).
BP4
REVEL score not calculable. SpliceAI predicts: Acceptor loss 0.00, Donor loss 0.00, Acceptor gain 0.00, Donor gain 0.00.
BP7
BP7: Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score -0.378488 < 2.0 or the variant is the reference nucleotide in one primate and/or three mammal species) (BP7).
Not Met criteria codes
PM6
No published literature was found for this variant.
PM1
This variant is outside the conserved RHD.
PM5
Synonymous variant, not applicable.
PM3
This rule is not applicable for MM-VCEP
PM4
Synonymous variant, not applicable
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
This rule is not applicable for MM-VCEP
BS4
No published literature was found for this variant.
BS3
No published literature was found for this variant.
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No published literature was found for this variant.
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
BP5
This rule is not applicable for MM-VCEP
PS2
No published literature was found for this variant.
PS4
No published literature was found for this variant.
PS3
No published literature was found for this variant.
PS1
Synonymous variant, not applicable.
PVS1
Synonymous variant, not applicable.
PP1
No published literature was found for this variant.
PP4
This rule is not applicable for MM-VCEP
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
This rule is not applicable for MM-VCEP
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.